Summit Investment Advisors »

Aclaris Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.2k 6.9k 1.05
2023-09-30 $47k 6.9k 6.85
2023-06-30 $54k 5.2k 10.37
2023-03-31 $42k 5.2k 8.09
2022-12-31 $86k 5.2k 16.59
2022-09-30 $71k 4.5k 15.64
2022-06-30 $63k 4.5k 13.88
2022-03-31 $69k 4.0k 17.34
2021-12-31 $58k 4.0k 14.58
2021-09-30 $72k 4.0k 18.10
2021-06-30 $60k 3.4k 17.63
2020-03-31 $2.0k 2.2k 0.89
2019-12-31 $4.0k 2.2k 1.79
2019-09-30 $2.0k 2.2k 0.89
2019-06-30 $5.0k 2.2k 2.23
2019-03-31 $13k 2.2k 5.81
2018-12-31 $17k 2.2k 7.60
2018-09-30 $32k 2.2k 14.30
2018-06-30 $45k 2.2k 20.11
2018-03-31 $31k 1.8k 17.52
2017-12-31 $44k 1.8k 24.87
2017-09-30 $45k 1.8k 25.44
2017-06-30 $48k 1.8k 27.13
2017-03-31 $21k 702 29.91